Li Y, Wu R, Tian X, Zhang M, Cheng Z
J Inflamm Res. 2024; 17:9469-9484.
PMID: 39606642
PMC: 11600937.
DOI: 10.2147/JIR.S484542.
Banerjee S, Sanyal S, Hodawadekar S, Naiyer S, Bano N, Banerjee A
Genes Dev. 2024; 38(17-20):887-914.
PMID: 39362773
PMC: 11535188.
DOI: 10.1101/gad.351734.124.
Lam J, Aboreden N, Midla S, Wang S, Huang A, Keller C
Nat Genet. 2024; 56(9):1938-1952.
PMID: 39210046
PMC: 11687402.
DOI: 10.1038/s41588-024-01871-y.
Qiu X, Liang G, Zhou W, Sen R, Atchison M
Aging Res. 2024; 1(1).
PMID: 38770228
PMC: 11103674.
DOI: 10.26599/agr.2023.9340010.
Cha J, Choi S
Int J Mol Sci. 2023; 24(15).
PMID: 37569643
PMC: 10419280.
DOI: 10.3390/ijms241512266.
Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.
Hosea R, Hillary S, Wu S, Kasim V
Cancers (Basel). 2023; 15(13).
PMID: 37444616
PMC: 10340792.
DOI: 10.3390/cancers15133506.
Neuroprotective protein ADNP-dependent histone remodeling complex promotes T helper 2 immune cell differentiation.
Ferreira A, Szeto A, Clark P, Crisp A, Kozik P, Jolin H
Immunity. 2023; 56(7):1468-1484.e7.
PMID: 37285842
PMC: 10501989.
DOI: 10.1016/j.immuni.2023.05.010.
Depletion of enhancer zeste homolog 2 (EZH2) directs transcription factors associated with T cell differentiation through epigenetic regulation of Yin Yang 1(YY1) in combating non-small cell lung cancer (NSCLC).
Chandnani N, Choudhari V, Talukdar R, Rakshit S, Shanmugam G, Guchait S
Med Oncol. 2023; 40(7):185.
PMID: 37212947
DOI: 10.1007/s12032-023-02053-2.
Dissecting the roles and clinical potential of YY1 in the tumor microenvironment.
Li M, Wei J, Xue C, Zhou X, Chen S, Zheng L
Front Oncol. 2023; 13:1122110.
PMID: 37081988
PMC: 10110844.
DOI: 10.3389/fonc.2023.1122110.
Molecular Mechanisms of T Helper Cell Differentiation and Functional Specialization.
Lee G
Immune Netw. 2023; 23(1):e4.
PMID: 36911803
PMC: 9995992.
DOI: 10.4110/in.2023.23.e4.
BRD4-PRC2 represses transcription of T-helper 2-specific negative regulators during T-cell differentiation.
Zhao L, Wang Y, Jaganathan A, Sun Y, Ma N, Li N
EMBO J. 2023; 42(6):e111473.
PMID: 36719036
PMC: 10015369.
DOI: 10.15252/embj.2022111473.
Neuronal-epithelial cross-talk drives acinar specification via NRG1-ERBB3-mTORC2 signaling.
May A, Mattingly A, Gaylord E, Griffin N, Sudiwala S, Cruz-Pacheco N
Dev Cell. 2022; 57(22):2550-2565.e5.
PMID: 36413949
PMC: 9727910.
DOI: 10.1016/j.devcel.2022.10.011.
Three-dimensional genome organization in immune cell fate and function.
Cuartero S, Stik G, Stadhouders R
Nat Rev Immunol. 2022; 23(4):206-221.
PMID: 36127477
DOI: 10.1038/s41577-022-00774-5.
The Transcription Factor YY-1 Is an Essential Regulator of T Follicular Helper Cell Differentiation.
Belanger S, Haupt S, Freeman B, Getzler A, Diao H, Pipkin M
J Immunol. 2022; 209(8):1566-1573.
PMID: 36096645
PMC: 11139054.
DOI: 10.4049/jimmunol.2101176.
3D Genome Organization as an Epigenetic Determinant of Transcription Regulation in T Cells.
Papadogkonas G, Papamatheakis D, Spilianakis C
Front Immunol. 2022; 13:921375.
PMID: 35812421
PMC: 9257000.
DOI: 10.3389/fimmu.2022.921375.
YY1 Is a Key Player in Melanoma Immunotherapy/Targeted Treatment Resistance.
Kwiatkowska D, Mazur E, Reich A
Front Oncol. 2022; 12:856963.
PMID: 35719931
PMC: 9198644.
DOI: 10.3389/fonc.2022.856963.
MicroRNA-18 facilitates the stemness of gastric cancer by downregulating HMGB3 though targeting Meis2.
Zhang Y, Lin W, Jiang W, Wang Z
Bioengineered. 2022; 13(4):9959-9972.
PMID: 35416122
PMC: 9161930.
DOI: 10.1080/21655979.2022.2062529.
The Protective Role of Yin-Yang 1 in Cardiac Injury and Remodeling After Myocardial Infarction.
Huang Y, Li L, Chen H, Liao Q, Yang X, Yang D
J Am Heart Assoc. 2021; 10(21):e021895.
PMID: 34713723
PMC: 8751820.
DOI: 10.1161/JAHA.121.021895.
miR-181a-regulated pathways in T-cell differentiation and aging.
Kim C, Ye Z, Weyand C, Goronzy J
Immun Ageing. 2021; 18(1):28.
PMID: 34130717
PMC: 8203492.
DOI: 10.1186/s12979-021-00240-1.
Deciphering the Complexity of 3D Chromatin Organization Driving Lymphopoiesis and Lymphoid Malignancies.
Scourzic L, Salataj E, Apostolou E
Front Immunol. 2021; 12:669881.
PMID: 34054841
PMC: 8160312.
DOI: 10.3389/fimmu.2021.669881.